M. Ohira

发表

Robust Model Selection for Classification of Microarrays

Shin Ishii, Ikumi Suzuki, Takashi Takenouchi, 2009, Cancer informatics.

Expression profiling using a tumor-specific cDNA microarray predicts the prognosis of intermediate risk neuroblastomas.

S. Ishii, M. Ohira, S. Oba, 2005, Cancer cell.

Alternative splicing and genomic structure of the AML1 gene involved in acute myeloid leukemia.

E. Soeda, K. Yokoyama, M. Ohira, 1995, Nucleic acids research.

Prediction of the coding sequences of unidentified human genes. VIII. 78 new cDNA clones from brain which code for large proteins in vitro.

N. Nomura, N. Miyajima, T. Nagase, 1997, DNA research : an international journal for rapid publication of reports on genes and genomes.

Correlation between the International Neuroblastoma Pathology Classification and genomic signature in neuroblastoma

M. Ohira, A. Nakagawara, T. Kamijo, 2015, Cancer science.

Revised Risk Estimation and Treatment Stratification of Low- and Intermediate-Risk Neuroblastoma Patients by Integrating Clinical and Molecular Prognostic Markers

Roland Eils, Gudrun Schleiermacher, Barbara Hero, 2014, Clinical Cancer Research.

ALK is a MYCN target gene and regulates cell migration and invasion in neuroblastoma

M. Ohira, Yohko Nakamura, A. Nakagawara, 2013, Scientific Reports.

Expression of NLRR3 Orphan Receptor Gene Is Negatively Regulated by MYCN and Miz-1, and Its Downregulation Is Associated with Unfavorable Outcome in Neuroblastoma

M. Ohira, A. Nakagawara, T. Ozaki, 2011, Clinical Cancer Research.

Accurate Outcome Prediction in Neuroblastoma across Independent Data Sets Using a Multigene Signature

Gudrun Schleiermacher, John M. Maris, Benedikt Brors, 2010, Clinical Cancer Research.

Expression of TSLC1, a candidate tumor suppressor gene mapped to chromosome 11q23, is downregulated in unfavorable neuroblastoma without promoter hypermethylation

M. Ohira, Yohko Nakamura, A. Nakagawa, 2008, International journal of cancer.

Increased expression of proapoptotic BMCC1, a novel gene with the BNIP2 and Cdc42GAP homology (BCH) domain, is associated with favorable prognosis in human neuroblastomas

M. Ohira, E. Isogai, T. Hirata, 2006, Oncogene.

High expression of N‐acetylglucosaminyltransferase V in favorable neuroblastomas: Involvement of its effect on apoptosis

J. Gu, M. Ohira, Yohko Nakamura, 2006, FEBS letters.

Prediction of MYCN amplification in neuroblastoma using serum DNA and real-time quantitative polymerase chain reaction.

M. Ohira, A. Nakagawara, H. Hosoi, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chromosomes that show partial loss or gain in near‐diploid tumors coincide with chromosomes that show whole loss or gain in near‐triploid tumors: Evidence suggesting the involvement of the same genes in the tumorigenesis of high‐ and low‐risk neuroblastomas

M. Ohira, Yohko Nakamura, A. Nakagawara, 2003, Genes, chromosomes & cancer.

High expression of Survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma

M. Ohira, E. Isogai, A. Nakagawara, 2000, Oncogene.

Recent trends in microRNA research into breast cancer with particular focus on the associations between microRNAs and intrinsic subtypes

Miki Ohira, Jun Horiguchi, Hiroshi Matsumoto, 2016, Journal of Human Genetics.

Construction and characterization of human brain cDNA libraries suitable for analysis of cDNA clones encoding relatively large proteins.

N. Nomura, T. Nagase, O. Ohara, 1997, DNA research : an international journal for rapid publication of reports on genes and genomes.

KIF1Bβ Functions as a Haploinsufficient Tumor Suppressor Gene Mapped to Chromosome 1p36.2 by Inducing Apoptotic Cell Death*

M. Ohira, A. Nakagawara, T. Ozaki, 2008, Journal of Biological Chemistry.

Y. Hayashi, M. Ohira, M. Ohki, 1993, Proceedings of the National Academy of Sciences of the United States of America.

Gene identification in 1.6-Mb region of the Down syndrome region on chromosome 21.

N. Nomura, M. Hattori, T. Saito, 1997, Genome research.

Sendai virus-mediated expression of reprogramming factors promotes plasticity of human neuroblastoma cells

M. Ohira, A. Nakagawara, Y. Suenaga, 2015, Cancer science.

Assignment of the E4TF1-60 gene to human chromosome 21q21.2-q21.3.

H. Handa, M. Ohira, M. Ohki, 1995, Gene.

HDM2 impairs Noxa transcription and affects apoptotic cell death in a p53/p73-dependent manner in neuroblastoma.

M. Ohira, A. Nakagawara, T. Kamijo, 2010, European journal of cancer.

Distinct role of ShcC docking protein in the differentiation of neuroblastoma

R. Sakai, M. Ohira, A. Nakagawara, 2009, Oncogene.

Identification of Genes Targeted by CpG Island Methylator Phenotype in Neuroblastomas, and Their Possible Integrative Involvement in Poor Prognosis

N. Watanabe, T. Ushijima, M. Ohira, 2008, Oncology.

Neurocan, an extracellular chondroitin sulfate proteoglycan, stimulates neuroblastoma cells to promote malignant phenotypes

M. Ohira, T. Kamijo, S. Kishida, 2017, Oncotarget.

Loss of imprinting of IGF2 correlates with hypermethylation of the H19 differentially methylated region in hepatoblastoma

Y. Arai, M. Ohira, A. Nakagawara, 2008, British Journal of Cancer.

Report and abstracts of the Sixth International Workshop on Human Chromosome 21 Mapping 1996. Cold Spring Harbor, New York, USA. May 6-8,1996.

John Quackenbush, R. Hubert, J. Korenberg, 1997, Cytogenetics and cell genetics.

Identification of the genetic and clinical characteristics of neuroblastomas using genome-wide analysis

S. Miyano, Y. Shiraishi, K. Chiba, 2017, Oncotarget.

The PRC2 molecule EED is a target of epigenetic therapy for neuroblastoma.

M. Ohira, T. Kamijo, R. Sugino, 2022, European journal of cell biology.

PPP3CB contributes to poor prognosis through activating nuclear factor of activated T‐cells signaling in neuroblastoma

M. Ohira, Yohko Nakamura, A. Nakagawara, 2018, Molecular carcinogenesis.

Genomic Amplifications and Distal 6q Loss: Novel Markers for Poor Survival in High-risk Neuroblastoma Patients

T. Hocking, F. Speleman, M. Fischer, 2018, Journal of the National Cancer Institute.

Identification of a novel human gene containing the tetratricopeptide repeat domain from the Down syndrome region of chromosome 21.

N. Nomura, T. Nagase, N. Seki, 1996, DNA research : an international journal for rapid publication of reports on genes and genomes.

Dependence receptor UNC5D mediates nerve growth factor depletion-induced neuroblastoma regression.

T. Ushijima, M. Ohira, Yohko Nakamura, 2013, The Journal of clinical investigation.

Identification and chromosome assignment of a human gene encoding a novel phosphatidylinositol-3 kinase.

N. Nomura, T. Saito, N. Seki, 1997, DNA research : an international journal for rapid publication of reports on genes and genomes.

NCYM, a Cis-Antisense Gene of MYCN, Encodes a De Novo Evolved Protein That Inhibits GSK3β Resulting in the Stabilization of MYCN in Human Neuroblastomas

W. Shoji, T. Shibata, M. Ohira, 2014, PLoS genetics.

High CC chemokine receptor 7 expression improves postoperative prognosis of lung adenocarcinoma patients

M. Ohira, Y. Yoshida, A. Nakagawara, 2013, British Journal of Cancer.

A novel HECT-type E3 ubiquitin protein ligase NEDL1 enhances the p53-mediated apoptotic cell death in its catalytic activity-independent manner

M. Ohira, A. Nakagawara, T. Ozaki, 2008, Oncogene.

Stronger prognostic power of the CpG island methylator phenotype than methylation of individual genes in neuroblastomas.

F. Westermann, M. Schwab, N. Watanabe, 2013, Japanese journal of clinical oncology.

Bcl-2 is a key regulator for the retinoic acid-induced apoptotic cell death in neuroblastoma

Y. Nakamura, M. Ohira, E. Isogai, 2006, Oncogene.

Prediction of the coding sequences of unidentified human genes. VI. The coding sequences of 80 new genes (KIAA0201-KIAA0280) deduced by analysis of cDNA clones from cell line KG-1 and brain.

N. Nomura, N. Miyajima, Y. Kawarabayasi, 1996, DNA research : an international journal for rapid publication of reports on genes and genomes.

Identification of novel human neuronal leucine-rich repeat (hNLRR) family genes and inverse association of expression of Nbla10449/hNLRR-1 and Nbla10677/hNLRR-3 with the prognosis of primary neuroblastomas.

M. Ohira, E. Isogai, A. Nakagawara, 2004, International journal of oncology.

A 1.6-Mb P1-based physical map of the Down syndrome region on chromosome 21.

K. Tashiro, M. Ohira, H. Ichikawa, 1996, Genomics.

Novel 1p tumour suppressor Dnmt1-associated protein 1 regulates MYCN/ataxia telangiectasia mutated/p53 pathway.

A. Iwama, M. Ohira, A. Nakagawara, 2014, European journal of cancer.

N-MYC promotes cell proliferation through a direct transactivation of neuronal leucine-rich repeat protein-1 (NLRR1) gene in neuroblastoma

M. Ohira, A. Nakagawa, A. Nakagawara, 2008, Oncogene.

PRC2-Mediated Transcriptomic Alterations at the Embryonic Stage Govern Tumorigenesis and Clinical Outcome in MYCN-Driven Neuroblastoma.

T. Shimamura, T. Ushijima, M. Ohira, 2017, Cancer research.

Molecular cloning and expression analysis of the human DA41 gene and its mapping to chromosome 9q21.2–q21.3

M. Ohira, Yohko Nakamura, A. Nakagawara, 2000, Journal of Human Genetics.

Identification of the small interstitial deletion at chromosome band 1p34–p35 and its association with poor outcome in oligodendroglial tumors

M. Ohira, A. Nakagawara, Y. Iwadate, 2002, Genes, chromosomes & cancer.

Oncogenic LMO3 Collaborates with HEN2 to Enhance Neuroblastoma Cell Growth through Transactivation of Mash1

M. Ohira, S. Oba, Yohko Nakamura, 2011, PloS one.

Retrospective Analysis of INRG Clinical and Genomic Factors for 605 Neuroblastomas in Japan: A Report from the Japan Children’s Cancer Group Neuroblastoma Committee (JCCG-JNBSG)

M. Ohira, Yohko Nakamura, A. Nakagawara, 2021, Biomolecules.

Transcriptional regulation of BMCC1 mediated by E2F1 in neuroblastoma cells.

M. Ohira, Yohko Nakamura, A. Nakagawara, 2016, Biochemical and biophysical research communications.

A new type of insertion mutation in monkey cells: insertion accompanied by long target site duplication

M. Ohira, Y. Bae, H. Ikeda, 1991, Molecular and General Genetics MGG.

Oncogenic Lmo3 cooperates with Hen2 to induce hydrocephalus in mice

M. Ohira, E. Isogai, A. Nakagawara, 2015, Experimental animals.

Analysis of loss of heterozygosity at 16p12-p13 (familial neuroblastoma locus) in 470 neuroblastomas including both sporadic and mass screening tumors.

M. Ohira, A. Nakagawara, S. Hamano, 2000, Medical and pediatric oncology.

Neuroblastoma oligo-capping cDNA project: toward the understanding of the genesis and biology of neuroblastoma.

S. Sugano, Yutaka Suzuki, M. Ohira, 2003, Cancer letters.

Infantile Stage M Neuroblastoma With 11q Deletion, Mimicking Stage MS

M. Ohira, T. Kamijo, H. Shichino, 2022, Journal of pediatric hematology/oncology.

Genomic analysis–integrated whole-exome sequencing of neuroblastomas identifies genetic mutations in axon guidance pathway

Huanming Yang, Jian Wang, Yong Zhou, 2017, Oncotarget.

The methylation status of RASSF1A promoter predicts responsiveness to chemotherapy and eventual cure in hepatoblastoma patients

M. Ohira, A. Nakagawara, S. Todo, 2008, International journal of cancer.

Neuronal leucine-rich repeat 1 negatively regulates anaplastic lymphoma kinase in neuroblastoma

M. Ohira, Yohko Nakamura, A. Nakagawara, 2016, Scientific Reports.

Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.

N. Nomura, N. Miyajima, T. Nagase, 1997, DNA research : an international journal for rapid publication of reports on genes and genomes.

A NotI restriction map of the entire long arm of human chromosome 21.

F. Hosoda, Y. Arai, M. Ohira, 1993, Nature genetics.

H. Kato, T. Tanaka, N. Seki, 1998, Biochemical and biophysical research communications.

Oncogenic mutations of ALK kinase in neuroblastoma

S. Ogawa, Y. Hayashi, M. Soda, 2008, Nature.

Structure of human holocarboxylase synthetase gene and mutation spectrum of holocarboxylase synthetase deficiency

K. Kawasaki, S. Minoshima, N. Shimizu, 2001, Human Genetics.

CpG island methylator phenotype is a strong determinant of poor prognosis in neuroblastomas.

A. Kaneda, Y. Yagi, T. Ushijima, 2005, Cancer research.

Specific chromosome aberrations in cells persistently infected with type 2 hemadsorption virus.

M. Ohira, M. Homma, N. Ishida, 1968, Virology.

Expression profiling and differential screening between hepatoblastomas and the corresponding normal livers: identification of high expression of the PLK1 oncogene as a poor-prognostic indicator of hepatoblastomas

S. Sugano, Yutaka Suzuki, M. Ohira, 2004, Oncogene.

Plasma midkine level is a prognostic factor for human neuroblastoma

M. Ohira, Yohko Nakamura, A. Nakagawara, 2008, Cancer science.

Novel adaptor protein Shf interacts with ALK receptor and negatively regulates its downstream signals in neuroblastoma

M. Ohira, A. Nakagawara, Y. Tatsumi, 2013, Cancer science.

Global genomic and RNA profiles for novel risk stratification of neuroblastoma

M. Ohira, A. Nakagawara, 2010, Cancer science.

ERAP140/Nbla10993 is a novel favorable prognostic indicator for neuroblastoma induced in response to retinoic acid.

H. Arai, M. Ohira, Yohko Nakamura, 2008, Oncology reports.

Stress via p53 pathway causes apoptosis by mitochondrial Noxa upregulation in doxorubicin-treated neuroblastoma cells

M. Ohira, A. Nakagawara, T. Kamijo, 2008, Oncogene.

Expression profiling and characterization of 4200 genes cloned from primary neuroblastomas: identification of 305 genes differentially expressed between favorable and unfavorable subsets

S. Sugano, Yutaka Suzuki, M. Ohira, 2003, Oncogene.

EZH2 regulates neuroblastoma cell differentiation via NTRK1 promoter epigenetic modifications

H. Aburatani, M. Ohira, A. Nakagawara, 2018, Oncogene.

Clinical significance of the 2016 WHO classification in Japanese patients with gliomas

M. Ohira, T. Iuchi, T. Sakaida, 2018, Brain Tumor Pathology.

CDK4 overexpression is a predictive biomarker for resistance to conventional chemotherapy in patients with osteosarcoma.

M. Ohira, H. Nagase, Y. Tatsumi, 2021, Oncology reports.

Meta-analysis of Neuroblastomas Reveals a Skewed ALK Mutation Spectrum in Tumors with MYCN Amplification

Frank Speleman, Rogier Versteeg, Isabelle Janoueix-Lerosey, 2010, Clinical Cancer Research.

Flotillin-1 regulates oncogenic signaling in neuroblastoma cells by regulating ALK membrane association.

R. Sakai, J. Takita, M. Ohira, 2014, Cancer research.

Krüppel-like factor 4 (KLF4) suppresses neuroblastoma cell growth and determines non-tumorigenic lineage differentiation

M. Ohira, A. Nakagawara, C. K. Shum, 2013, Oncogene.

LMO3 interacts with neuronal transcription factor, HEN2, and acts as an oncogene in neuroblastoma.

Miki Ohira, Akira Nakagawara, M. Ohira, 2005, Cancer research.

Functional interplay between MYCN, NCYM, and OCT4 promotes aggressiveness of human neuroblastomas

M. Ohira, Yohko Nakamura, A. Nakagawara, 2015, Cancer science.

Risk Estimation and Treatment Strati fi cation of Low-and Intermediate-Risk Neuroblastoma Patients by Integrating Clinical and Molecular Prognostic Markers

R. Eils, F. Westermann, F. Berthold, 2015 .

RUNX3 interacts with MYCN and facilitates protein degradation in neuroblastoma

Y. Nakamura, M. Ohira, Yohko Nakamura, 2014, Oncogene.

A review of DNA microarray analysis of human neuroblastomas.

S. Ishii, M. Ohira, S. Oba, 2005, Cancer letters.

Aberrant methylation of FBN2 in human non-small cell lung cancer.

M. Ohira, Yohko Nakamura, A. Nakagawara, 2005, Lung cancer.

Genomic analysis-integrated whole-exome sequencing of neuroblastomas identifies genetic mutations in axon guidance pathway.

Huanming Yang, Jian Wang, Yong Zhou, 2017, Oncotarget.

Results of a phase II trial for high-risk neuroblastoma treatment protocol JN-H-07: a report from the Japan Childhood Cancer Group Neuroblastoma Committee (JNBSG)

M. Ohira, A. Nakagawara, T. Kamijo, 2018, International Journal of Clinical Oncology.

Loss of DNA Damage Response in Neuroblastoma and Utility of a PARP Inhibitor

S. Miyano, S. Ogawa, Y. Hayashi, 2017, Journal of the National Cancer Institute.

Cell culture and Drosophila model systems define three classes of anaplastic lymphoma kinase mutations in neuroblastoma

M. Marra, O. Morozova, J. Maris, 2012, Disease Models & Mechanisms.

Clinical Cancer esearch an Cancer Biology a-analysis of Neuroblastomas Reveals a Skewed ALK R ation Spectrum in Tumors with MYCN Amplification

Vermeulen, F. Speleman, J. Vandesompele, 2010 .

Biological role of anaplastic lymphoma kinase in neuroblastoma.

R. Sakai, M. Ohira, A. Nakagawa, 2005, The American journal of pathology.

Sixty new STSs (sequence-tagged sites) of human chromosome 21.

M. Hattori, T. Ito, K. Tashiro, 1994, DNA research : an international journal for rapid publication of reports on genes and genomes.

A Notl restriction map of the entire long arm of human chromosome 21

F. Hosoda, Y. Arai, M. Ohira, 1993, Nature Genetics.

TAp63 represses transcription of MYCN/NCYM gene and its high levels of expression are associated with favorable outcome in neuroblastoma.

M. Ohira, A. Nakagawara, T. Ozaki, 2019, Biochemical and biophysical research communications.

Bmi1 is a MYCN target gene that regulates tumorigenesis through repression of KIF1Bβ and TSLC1 in neuroblastoma

M. Kimura, M. Ohira, A. Nakagawa, 2010, Oncogene.

A novel potent tumour promoter aberrantly overexpressed in most human cancers

M. Ohira, A. Nakagawara, H. Tokita, 2011, Scientific reports.

Relationship of DDX1 and NAG gene amplification/overexpression to the prognosis of patients with MYCN-amplified neuroblastoma

M. Ohira, Yohko Nakamura, E. Isogai, 2007, Journal of Cancer Research and Clinical Oncology.

Identification of the p33(ING1)-regulated genes that include cyclin B1 and proto-oncogene DEK by using cDNA microarray in a mouse mammary epithelial cell line NMuMG.

N. Seki, M. Ohira, A. Nakagawara, 2002, Cancer research.

in a Mouse Mammary Epithelial Cell Line NMuMG by Using cDNA Microarray DEK and Proto-oncogene Cyclin B 1-regulated Genes that Include ING 1 Identification of the p 33 Updated

N. Seki, M. Ohira, A. Nakagawara, 2002 .

ALK fusion gene positive lung cancer and 3 cases treated with an inhibitor for ALK kinase activity.

M. Soda, H. Mano, M. Ohira, 2012, Lung cancer.

Identification of novel mutations in Japanese ovarian clear cell carcinoma patients using optimized targeted NGS for clinical diagnosis.

M. Ohira, H. Nagase, N. Tanaka, 2017, Gynecologic oncology.

Functional characterization of a new p53 mutant generated by homozygous deletion in a neuroblastoma cell line.

M. Ohira, Yohko Nakamura, A. Nakagawara, 2007, Biochemical and biophysical research communications.

Comprehensive genomics linking between neural development and cancer: neuroblastoma as a model.

Miki Ohira, Akira Nakagawara, M. Ohira, 2004, Cancer letters.

Modified expression of Mts1/S100A4 protein in C6 glioma cells or surrounding astrocytes affects migration of tumor cells in vitro and in vivo

Miki Ohira, M. Ohira, M. Sjöquist, 2007, Neurobiology of Disease.

Tokuda Akihiro Tomida Shinya Toyokuni Hitoshi Tsuda Shoichiro Tsugane Tatsuhiko Tsunoda Heiichiro Udono Koji Ueda Yoshimasa Uehara Hiroo Ueno Kazuo Umezawa Toshikazu Ushijima Toshihiko Wakabayashi Kenji Wakai Tetsuro Watabe

H. Aburatani, S. Hirota, Y. Kaneda, 2016 .

Characterization of cDNA clones in size-fractionated cDNA libraries from human brain.

N. Nomura, N. Miyajima, T. Nagase, 1997, DNA research : an international journal for rapid publication of reports on genes and genomes.

CD133 suppresses neuroblastoma cell differentiation via signal pathway modification

T. Nakamura, M. Ohira, A. Nakagawara, 2011, Oncogene.

Specific mitochondrial DNA mutation in mice regulates diabetes and lymphoma development

J. Hayashi, M. Ohira, H. Nagase, 2012, Proceedings of the National Academy of Sciences.

Association between favorable neuroblastoma and high expression of the novel metalloproteinase gene, nbla3145/XCE, cloned by differential screening of the full-length-enriched oligo-capping neuroblastoma cDNA libraries.

Y. Suzuki, S. Sugano, M. Ohira, 2000, Medical and pediatric oncology.

The genomic analysis of human DAN gene.

N. Nomura, N. Seki, M. Ohira, 1997, DNA and cell biology.

Comparative epigenomics by machine learning approach for neuroblastoma

M. Ohira, T. Kamijo, R. Sugino, 2022, BMC Genomics.

High expression of ncRAN, a novel non-coding RNA mapped to chromosome 17q25.1, is associated with poor prognosis in neuroblastoma.

M. Ohira, S. Oba, Yohko Nakamura, 2009, International journal of oncology.

N. Nomura, N. Seki, M. Ohira, 1998, International journal of cancer.

Targeting FROUNT with disulfiram suppresses macrophage accumulation and its tumor-promoting properties

K. Matsushima, M. Ohira, H. Nagase, 2020, Nature Communications.

Novel risk stratification of patients with neuroblastoma by genomic signature, which is independent of molecular signature

D Pinkel, S Todo, S. Ishii, 2008, Oncogene.

Isolation and chromosomal assignment of human genes encoding cofactor of LIM homeodomain proteins, CLIM1 and CLIM2

Yasuhiko Masuho, Toshiyuki Saito, Miki Ohira, 1999, Journal of Human Genetics.

Loss of p53 suppresses replication stress-induced DNA damage in ATRX-deficient neuroblastoma

M. Ohira, K. Ando, T. Kamijo, 2021, Oncogenesis.

Increased susceptibility to tumorigenesis of ski-deficient heterozygous mice

S. Ishii, M. Ohira, A. Nakagawara, 2001, Oncogene.

p73 at chromosome 1p36.3 is lost in advanced stage neuroblastoma but its mutation is infrequent

F. McKeon, D. Caput, N. Seki, 1999, Oncogene.

Nonsense suppressor mutants of bacteriophage BF23.

H. Ozeki, M. Ohira, K. Okada, 1978, Virology.

A shuttle vector for analysis of illegitimate recombination in mammalian cells: effects of DNA topoisomerase inhibitors on deletion frequency.

M. Ohira, Y. Bae, H. Ikeda, 1991, Gene.

Isolation, tissue expression, and chromosomal assignment of human RGS5, a novel G-protein signaling regulator gene

S. Sugano, Yutaka Suzuki, N. Seki, 1998, Journal of Human Genetics.

Hunting the subset-specific genes of neuroblastoma: expression profiling and differential screening of the full-length-enriched oligo-capping cDNA libraries.

Y. Suzuki, S. Sugano, M. Ohira, 2000, Medical and pediatric oncology.

A BAC-based STS-content map spanning a 35-Mb region of human chromosome 1p35-p36.

F. Hosoda, J. Inazawa, Y. Arai, 2001, Genomics.

Complementary DNA cloning and chromosomal mapping of a novel phosphatidylinositol kinase gene.

T. Saito, N. Seki, M. Ohira, 1997, DNA research : an international journal for rapid publication of reports on genes and genomes.

Structure, expression profile and chromosomal location of an isolog of DNA-PKcs interacting protein (KIP) gene.

T. Saito, N. Seki, M. Ohira, 1999, Biochimica et biophysica acta.

CFC1 is a cancer stemness-regulating factor in neuroblastoma

M. Kurosumi, M. Ohira, T. Kamijo, 2017, Oncotarget.

Identification of the full-length KIAA0591 gene encoding a novel kinesin-related protein which is mapped to the neuroblastoma suppressor gene locus at 1p36.2.

N. Nomura, K. Takakura, N. Seki, 2000, International journal of oncology.

Identification and characterization of a 500-kb homozygously deleted region at 1p36.2-p36.3 in a neuroblastoma cell line

Yoshiyuki Sakaki, Masahira Hattori, Misao Ohki, 2000, Oncogene.

Aberrant methylation of RASGRF 2 and RASSF 1 A in human non-small cell lung cancer

M. Ohira, Yohko Nakamura, A. Nakagawara, 2022 .

Identification of a novel E-box binding pyrrole-imidazole polyamide inhibiting MYC-driven cell proliferation

M. Kimura, C. Grandori, M. Ohira, 2015, Cancer science.

FGFR2 loss sensitizes MYCN‐amplified neuroblastoma CHP134 cells to CHK1 inhibitor–induced apoptosis

M. Makishima, M. Ohira, H. Nagase, 2021, Cancer science.

ATM depletion induces proteasomal degradation of FANCD2 and sensitizes neuroblastoma cells to PARP inhibitors

M. Ohira, K. Ando, T. Kamijo, 2023, BMC Cancer.

Assignment of the ZIP kinase gene to human chromosome 19p13.3 by somatic hybrid analysis and fluorescence in-situ hybridization

N. Seki, M. Ohira, A. Hayashi, 1998, Journal of Human Genetics.

A MYCN-amplified cell line derived from a long-term event-free survivor among our sixteen established neuroblastoma cell lines.

M. Ohira, A. Nakagawara, H. Hosoi, 2013, Cancer letters.

Polycomb EZH1 regulates cell cycle/5‐fluorouracil sensitivity of neuroblastoma cells in concert with MYCN

M. Ohira, K. Ando, T. Kamijo, 2022, Cancer science.

Characterization of a human homolog (BACH1) of the mouse Bach1 gene encoding a BTB-basic leucine zipper transcription factor and its mapping to chromosome 21q22.1.

N. Nomura, T. Nagase, O. Ohara, 1998, Genomics.

Low expression of human tubulin tyrosine ligase and suppressed tubulin tyrosination/detyrosination cycle are associated with impaired neuronal differentiation in neuroblastomas with poor prognosis

M. Ohira, Yohko Nakamura, A. Nakagawa, 2004, International journal of cancer.

A novel potent tumour promoter aberrantly overexpressed in most human cancers

M. Ohira, A. Nakagawara, H. Tokita, 2011, Scientific reports.

Development of an osteosarcoma model with MYCN amplification and TP53 mutation in hiPS cell‐derived neural crest cells

M. Ohira, T. Kamijo, J. Toguchida, 2023, Cancer science.

Identification of the homozygously deleted region at chromosome 1p36.2 in human neuroblastoma.

M. Hattori, Y. Sakaki, Y. Nakamura, 2000, Medical and pediatric oncology.

High expression of the novel endothelin-converting enzyme genes, Nbla03145/ECEL1α and β, is associated with favorable prognosis in human neuroblastomas

M. Ohira, A. Nakagawara, S. Hamano, 2003 .

Concordance for neuroblastoma in monozygotic twins: case report and review of the literature.

A. Suminoe, T. Hara, M. Ohira, 2010, Journal of pediatric surgery.

Combfit: A Normalization Method for Array CGH Data

Shin Ishii, Shigeyuki Oba, Miki Ohira, 2006 .

Aberrant methylation of RASGRF2 and RASSF1A in human non-small cell lung cancer.

Miki Ohira, Hideki Kimura, Soichiro Ando, 2006, Oncology reports.

Pediatric Precision Medicine at the National Cancer Center Japan: Prospective Genomic Study of Pediatric Patients with Cancer as Part of the TOP-GEAR Project.

T. Kohno, Teruhiko Yoshida, M. Hirata, 2023, JCO precision oncology.

Temozolomide suppresses MYC via activation of TAp63 to inhibit progression of human glioblastoma

M. Ohira, A. Nakagawara, Y. Suenaga, 2013, Scientific Reports.

Genetic analysis of p73 localized at chromosome 1p36.3 in primary neuroblastomas.

F. McKeon, D. Caput, N. Seki, 2001, Medical and pediatric oncology.

A distamycin A-inducible fragile site, FRA8E, located in the region of the hereditary multiple exostoses gene, is not involved in HPV16 DNA integration and amplification.

N. Seki, M. Ohira, T. Imai, 1998, Cancer genetics and cytogenetics.

Alterations in the glycoform of cisplatin-resistant human carcinoma cells are caused by defects in the endoplasmic reticulum-associated degradation system.

H. Kondo, M. Ohira, A. Nakagawara, 2008, Cancer letters.

Accurate Outcome Prediction in Neuroblastoma across Independent Data Sets Using a Multigene Signature

F. Westermann, J. Mora, F. Speleman, 2010, Clinical Cancer Research.

Neurexophilin-1 and neurexophilin-2 are novel prognostic factors for human neuroblastoma

M. Ohira, A. Nakagawara, H. Mugishima, 2005 .

Tumorigenesis and Neoplastic Progression Biological Role of Anaplastic Lymphoma Kinase in Neuroblastoma

R. Sakai, M. Ohira, A. Nakagawa, 2005 .

Identification of Genes Targeted by CpG Island Methylator Phenotype in Neuroblastomas, and Their Possible Integrative Involvement in Poor Prognosis

N. Watanabe, T. Ushijima, M. Ohira, 2008, Oncology.